Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. 2005

Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
Department of Neurology, Philipps-Universität Marburg, Germany.

Oxidative stress is a major contributing factor in the pathogenesis of Parkinson's disease. We therefore investigated the effect of the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) on hydroxyl-free radical and peroxynitrite formation in the intrastriatal 6-OHDA rat model of Parkinson's disease. The hydroxylation product of salicylate (2,3-dihydroxy-benzoic acid) as well as the hydroxylation and nitration products of d-phenylalanine (2- and 3-hydroxyl-phenylalanine, nitrotyrosine and nitrophenylalanine) were assessed in tissue samples of the striatum and, for the first time, the substantia nigra of adult rats at four different time points (25 min, 2 h, 4 h and 7 days) after unilateral stereotaxic intrastriatal injection of 6-OHDA. In the striatum, maxima of hydroxylating and nitrating markers were found at early time points after 6-OHDA lesion. These results suggest a direct interrelation between 6-OHDA-autoxidation and/or the increased dopamine turnover and hydroxyl-free radical and peroxynitrite formation. In the substantia nigra, i.e., at a distance from the injection site of the neurotoxin, an increase in hydroxyl-free radical formation was observed at 7 days after 6-OHDA lesion, with this modification possibly being independent of 6-OHDA autoxidation and rather representing a long-term effect of the toxin. Furthermore, we conclude that apart from the formation of reactive oxygen species, the production of reactive nitrogen species occurs in this experimental Parkinson's disease model. Finally, the similarity between the 6-OHDA model and Parkinson's disease supports the notion that reactive oxygen species as well as reactive nitrogen species may play an important role in the pathogenesis of this neurodegenerative disorder.

UI MeSH Term Description Entries
D007839 Functional Laterality Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. Ambidexterity,Behavioral Laterality,Handedness,Laterality of Motor Control,Mirror Writing,Laterality, Behavioral,Laterality, Functional,Mirror Writings,Motor Control Laterality,Writing, Mirror,Writings, Mirror
D008297 Male Males
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
October 2016, Neuroscience,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
February 1976, European journal of pharmacology,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
January 1999, Neuroscience,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
October 1991, Brain research,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
June 2004, Brain research,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
January 1990, Neuroscience,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
August 2003, British journal of pharmacology,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
March 2000, Journal of neurochemistry,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
September 1990, Brain research,
Carmen Henze, and Christopher Earl, and Jürgen Sautter, and Nicole Schmidt, and Claudia Themann, and Andreas Hartmann, and Wolfgang H Oertel
May 1973, British journal of pharmacology,
Copied contents to your clipboard!